Metformin Recalled Due to Link to NDMA & Cancer

There are several extended-release lots of the type-2 diabetes medication, Metformin, that contain high levels of N-Nitrosodimethylamine (NDMA), a cancer-causing chemical, according to the Food and Drug Administration (FDA). They are asking several drug manufacturers to recall the medication voluntarily.

The agency found these high levels primarily in the extended-release formulation of the medication, which is the reason behind the recalls.

Read entire post on Broughton Partners.

Leave a Reply

Your email address will not be published. Required fields are marked *